SHARE

Archimed acquires majority stake in two biologic therapeutics companies

Archimed has taken a majority stake in ExcellGene and Magellan Biologics and Consulting. The family-founded firms specialise in biologic therapeutics, offering high-throughput cell culture, transfection products and advanced cell culture media.

Certification Note

Certified B Corporation” is a trademark licensed by B Lab, a private non-profit organization, to companies like ours that have successfully completed the B Impact Assessment (“BIA”) and therefore meet the requirements set by B Lab for social and environmental performance, accountability, and transparency. It is specified that B Lab is not a conformity assessment body as defined by Regulation (EU) No 765/2008, nor is it a national, European, or international standardization body as per Regulation (EU) No 1025/2012. The criteria of the BIA are distinct and independent from the harmonized standards resulting from ISO norms or other standardization bodies, and they are not ratified by national or European public institutions.